ISFAHAN UNIVERSITY OF MEDICAL SCIENCES
🇮🇷Iran
Clinical Trials
2.0k
Active:4
Completed:876
Trial Phases
6 Phases
Early Phase 1:8
Phase 1:44
Phase 2:367
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2022 trials with phase data)• Click on a phase to view related trials
Not Applicable
892 (44.1%)Phase 3
682 (33.7%)Phase 2
367 (18.2%)Phase 1
44 (2.2%)Phase 4
29 (1.4%)Early Phase 1
8 (0.4%)3D Eye Movement Simulator for Medical Education
Not Applicable
Not yet recruiting
- Conditions
- EducationEducation, Medical, UndergraduateEducation, Medical
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 76
- Registration Number
- NCT07031960
Construction and Educational Impact of Plastination Models of the Limbic System, Basal Nuclei, Cerebellum, and Human Spinal Cord
Not Applicable
Not yet recruiting
- Conditions
- EducationEducation, MedicalEducation, Medical, Undergraduate
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT06991933
Comparative Efficacy of ADM Hydrogel vs. Alginate Dressings in Chronic Trauma Wounds
Not Applicable
Not yet recruiting
- Conditions
- Trauma Wounds
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 130
- Registration Number
- NCT06978569
- Locations
- 🇮🇷
Alzahra hospital, Isfahan, Iran, Islamic Republic of
The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome
Phase 1
Recruiting
- Conditions
- PCO - Polycystic OvariesObesity and Obesity-related Medical Conditions
- Interventions
- Drug: Subjects in the intervention group will receive one capsule containing 10 mg Astaper day made by the "Zyest Technology Tarawat Zendig" institute in Iran. The dosage of ASX is determined based on the sDrug: Placebo
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 44
- Registration Number
- NCT06642363
- Locations
- 🇮🇷
Isfahan university of medical sciences, Isfahan, Iran, Islamic Republic of
Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
Phase 2
Recruiting
- Conditions
- Diabetic Macular EdemaMacular EdemaRetinal Neovascularization
- First Posted Date
- 2024-09-13
- Last Posted Date
- 2024-09-13
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 52
- Registration Number
- NCT06595355
- Prev
- 1
- 2
- 3
- 4
- 5
- 30
- Next
News
No news found